Health Bulletin 10/October/2023 Roshni Dhar10 Oct 2023 5:02 PM ISTHere are the top health stories for the day:Baba Ramdev appeals against criminal action over alleged anti-allopathy remarks during covid pandemic, SC...
Union Health Ministry notifies 300 drug brands under Schedule H2, Details Farhat Nasim21 Nov 2022 5:38 PM ISTNew Delhi: The Union Health Ministry has mandated Barcode or Quick Response (QR) Code on the label of top 300 brands of drugs including Dolo, Allegra,...
Govt picks top 300 drug brands including Dolo, Saridon, FabiFlu to issue unique QR code Susmita Roy4 Jun 2022 5:26 PM ISTNew Delhi: India's drug pricing authority, the National Pharmaceuticals Pricing Authority, has picked the top 300 medicine brands that would be...
Glenmark concludes PMS study on Favipiravir in COVID patients Ruchika Sharma17 Sept 2021 1:03 PM ISTMumbai: Drugmaker, Glenmark Pharmaceuticals, has recently announced the successful completion of its Post Marketing Surveillance (PMS) study on...
Glenmark profit after tax up 21 percent at Rs 306 crore in Q1 Ruchika Sharma15 Aug 2021 9:00 AM ISTNew Delhi: Glenmark Pharmaceuticals on Friday said its consolidated profit after tax (PAT) increased by 21 per cent to Rs 306 crore for the first...
Prosecution launched against Gautam Gambhir Foundation, 2 AAP MLAs in covid drugs case: Delhi Drugs Control Dept tells court Ruchika Sharma19 July 2021 11:30 AM ISTThe counsel for drug controller said that show cause notices have been issued to licensees under the Drugs and Cosmetics Act as well as those who were...
Glenmark PMS Study interim data supports favipiravir safety, effectiveness Ruchika Sharma9 Jun 2021 10:00 AM ISTMumbai: Pharma major, Glenmark Pharmaceuticals, has recently announced interim data of 503 patients from its Post Marketing Surveillance (PMS) study...
Indian Pharma sees robust growth of 51.5 percent in April sales: AIOCD-AWACS Report Medical Dialogues Team14 May 2021 11:00 AM ISTNew Delhi: The performance of the Indian Pharmaceutical Market (IPM) in April has portrayed a positive outlook for the Indian pharmaceutical industry...
Glenmark FabiFlu knocks out top-selling Zincovit with April sales of Rs 352 crore Medical Dialogues Team11 May 2021 6:40 PM ISTMumbai: Knocking out top-selling multivitamin brand Zincovit, Glenmark Pharmaceutical's Covid-19 drug Favipiravir, marketed as FabiFlu secured the...
Favipiravir shows significant improvement in COVID clinical cure: Glenmark Ruchika Sharma24 Nov 2020 1:00 PM ISTFavipiravir is an antiviral medication that works by inhibiting a viral enzyme called RdRP (RNA dependent RNA polymerase), thereby halting the virus's...
Glenmark to introduce stronger version of FabiFlu in India for COVID treatment Ruchika Sharma7 Aug 2020 1:19 PM ISTGlenmark is the first company in India to have received regulator Drug Controller General of India's approval for the 400 mg dosage form, the...
Cipla to soon unveil COVID drug Ciplenza for Rs 68 MD Bureau25 July 2020 11:00 AM ISTCipla said it will commercially launch Ciplenza in the first week of August priced at Rs 68 per tablet.
